Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their written agreement to take part, before any screening begins (or whose legal representative has done so on their behalf)
- People who are at least 18 years old at the time of signing the consent form
- People who have been assessed by a doctor as having a suspected acute coronary syndrome (such as unstable angina or a type of heart attack called NSTEMI), or a chronic coronary syndrome (such as stable angina or silent ischemia, which is reduced blood flow to the heart without obvious symptoms)
Who may not be able to join:
- People who have been assessed as having a specific type of heart attack called a STEMI
- People whose blood pressure or circulation is dangerously unstable at the time of the trial
- People who have serious irregular heart rhythms originating in the lower chambers of the heart
- People with a severe level of heart failure (classified by doctors as Killip class III or IV)
- People whose kidneys are functioning at a low level (below a certain threshold on a standard kidney function calculation), unless they are already receiving ongoing dialysis treatment — people on long-term dialysis may still be considered eligible regardless of their kidney function result
- People with severely twisted or curved coronary arteries (confirm with trial site)
- People who have a known allergy to the dye used in imaging procedures, where that allergy cannot be adequately managed with pre-treatment medication
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tom Adriaenssens, MD PhD, UZ Leuven
Phone: +3216344235
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diagnostic accuracy of coronary PCCT angiography.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.